4 in 5 Businesses Affirm That Workflow Automation Enhances Employees’ Work Rather Than Replace Them, But a Knowledge Gap Persists
81% of employers say that workflow automation will enhance employees' work instead of replacing them,…
5 years ago
Amazon Singapore empowers women-owned small businesses this International Women’s Day
Amazon Singapore encourages consumers to shop from small businesses and bolsters support for sellers by…
5 years ago
Working together, the Akita Shirakami area rethinks tourism in the age of Covid-19 through new PR video and grassroots project
AKITA PREFECTURE, JAPAN - Media OutReach - 5 March 2021 - Focusing on community collaboration,…
5 years ago
Benchmark International Successfully Facilitated the Transaction Between ParcelNinja (Pty) LTD and Imperial Holdings LTD
Capetown, South Africa, March 04, 2021 --(PR.com)-- Benchmark International is pleased to announce the transaction…
5 years ago
NANOBIOTIX and PharmaEngine Mutually Agree to Conclude Collaboration
PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the…
5 years ago
Ouster and QCraft Announce Recent Launch of Robobus Fleet in China Using Ouster Lidar Sensors
QCraft rolled out its third fleet of robobuses in January 2021 SAN FRANCISCO & SUZHOU,…
5 years ago
Face the Yokai Monsters and Take Your “Home Sweet Home” Back! – The Latest Hyper Casual Game From 3goo K.K. “Yokai Battle” Is Released on Android!
Armed with unique weapons, defeat the funny and bizarre monsters from Japanese mythology. TOKYO--(BUSINESS WIRE)--3goo…
5 years ago
Genetron Health to Announce Fourth Quarter and Full Year 2020 Unaudited Financial Results and Host Investor Call on March 25, 2021
BEIJING--(BUSINESS WIRE)--Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform…
5 years ago
Coeur to Participate in Upcoming NYSE Materials Investor Access Day
CHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc.’s (“Coeur” or the “Company”) (NYSE: CDE) President and Chief Executive Officer,…
5 years ago
Brii Biosciences Antibody Combination Will Not Progress into a Phase 3 Study Evaluating the Treatment of SARS-CoV-2 in Hospitalized Patients
- The complete dataset from this study is evolving, including important sensitivity and sub-group analysis,…
5 years ago